Stuart Shapiro - Search Results

Year	Number of Results
2002	3
2003	1
2004	4
2005	2
2006	3
2007	2
2008	2
2009	2
2010	1
2011	2
2012	2
2013	3
2014	2
2015	3
2016	2
2017	4
2018	5
2019	5
2020	4
2021	6
2022	3
2024	2

1

HIV Vaccine Development: 35 Years of Experimenting in the Funding of Biomedical Research.

Shapiro SZ. Shapiro SZ. Viruses. 2020 Dec 19;12(12):1469. doi: 10.3390/v12121469. Viruses. 2020. PMID: 33352755 Free PMC article. Review.

2

Lessons for general vaccinology research from attempts to develop an HIV vaccine.

Shapiro SZ. Shapiro SZ. Vaccine. 2019 Jun 6;37(26):3400-3408. doi: 10.1016/j.vaccine.2019.04.005. Epub 2019 Apr 9. Vaccine. 2019. PMID: 30979571 Review.

3

HIV vaccine development: strategies for preclinical and clinical investigation.

Shapiro SZ. Shapiro SZ. AIDS Res Hum Retroviruses. 2013 Nov;29(11):1401-6. doi: 10.1089/AID.2012.0337. Epub 2013 Mar 8. AIDS Res Hum Retroviruses. 2013. PMID: 23379343 Free PMC article. Review.

4

Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing Enterobacterales.

Shapiro S. Shapiro S. Antimicrob Agents Chemother. 2022 May 17;66(5):e0029822. doi: 10.1128/aac.00298-22. Epub 2022 Apr 26. Antimicrob Agents Chemother. 2022. PMID: 35471043 Free PMC article. No abstract available.

5

Neutron stars harboring a primordial black hole: Maximum survival time.

Baumgarte TW, Shapiro SL. Baumgarte TW, et al. Among authors: shapiro sl. Phys Rev D. 2021 Apr 15;103(8):L081303. doi: 10.1103/physrevd.103.l081303. Epub 2021 Apr 22. Phys Rev D. 2021. PMID: 34589636 Free PMC article.

6

Whose norm?

Shapiro SC. Shapiro SC. Trends Cogn Sci. 2002 Nov 1;6(11):490. doi: 10.1016/s1364-6613(02)01997-6. Trends Cogn Sci. 2002. PMID: 12457903 No abstract available.

7

Speculative strategies for new antibacterials: all roads should not lead to Rome.

Shapiro S. Shapiro S. J Antibiot (Tokyo). 2013 Jul;66(7):371-86. doi: 10.1038/ja.2013.27. Epub 2013 Apr 24. J Antibiot (Tokyo). 2013. PMID: 23612725 Review.

8

Workshop summary: Novel biomarkers for HIV incidence assay development.

Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, Shapiro S, McMichael A, Burns DN. Sharma UK, et al. Among authors: shapiro s. AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9. doi: 10.1089/aid.2011.0332. Epub 2012 Feb 24. AIDS Res Hum Retroviruses. 2012. PMID: 22206265 Free PMC article.

9

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?

Sheets RL, Rangavajhula V, Pullen JK, Butler C, Mehra V, Shapiro S, Pensiero M. Sheets RL, et al. Among authors: shapiro s. Vaccine. 2015 Apr 8;33(15):1757-66. doi: 10.1016/j.vaccine.2015.02.003. Epub 2015 Feb 16. Vaccine. 2015. PMID: 25698494 Free PMC article. Review.

10

Clinical development of candidate HIV vaccines: different problems for different vaccines.

Shapiro SZ. Shapiro SZ. AIDS Res Hum Retroviruses. 2014 Apr;30(4):325-9. doi: 10.1089/AID.2013.0114. Epub 2013 Nov 22. AIDS Res Hum Retroviruses. 2014. PMID: 24168166 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year